Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

MPN

Chokri Ben Lamine: PNH beyond the Textbook Triad
Oct 10, 2026, 17:30 | Science
Chokri Ben Lamine: PNH beyond the Textbook Triad
Chokri Ben Lamine, Hematologist at King Faisal Specialist Hospital and Research Center, shared a post…
Alessandro Lucchesi: RiseMPN 2026 - Shaping the Future of MPN Treatment
Oct 2, 2026, 13:49 | Voices
Alessandro Lucchesi: RiseMPN 2026 - Shaping the Future of MPN Treatment
Alessandro Lucchesi, Consultant Hematologist at Romagna Scientific Institute for the Study and Treatment of Cancer…
Fatma Al Arbawi: Studying Blood Clot Mechanics to Understand Aspirin Resistance and Thrombosis
Sep 30, 2026, 22:19 | Voices
Fatma Al Arbawi: Studying Blood Clot Mechanics to Understand Aspirin Resistance and Thrombosis
Fatma Al Arbawi, Researcher at Dartmouth Hitchcock Medical Center and Clinics, Research Assistant at Geisel…
Shehab Mohamed: TP53 Mutations and Outcomes in Myeloproliferative Neoplasms
Sep 24, 2026, 12:44 | Science
Shehab Mohamed: TP53 Mutations and Outcomes in Myeloproliferative Neoplasms
Shehab Mohamed, Hematologist at Hamad Medical Corporation, shared a post on LinkedIn about a recent article…
Priya Sriskandarajah: The Challenge of Thrombotic Risk in Myeloproliferative Neoplasms
Sep 13, 2026, 13:50 | Science
Priya Sriskandarajah: The Challenge of Thrombotic Risk in Myeloproliferative Neoplasms
Priya Sriskandarajah, Consultant Haematologist at Guy’s and St Thomas’​ NHS Foundation Trust, shared a post…
Gabriela Hobbs: 2026 Society of Hematologic Oncology Meeting
Sep 13, 2026, 04:22 | Voices
Gabriela Hobbs: 2026 Society of Hematologic Oncology Meeting
Gabriela Hobbs, Leukemia Clinical Director at Massachusetts General Hospital, Associate Professor at Harvard Medical School…
Alessandro Lucchesi: The Future of MPN Disease Modification
Sep 9, 2026, 15:39 | Voices
Alessandro Lucchesi: The Future of MPN Disease Modification
Alessandro Lucchesi, Consultant Hematologist at Romagna Scientific Institute for the Study and Treatment of Cancer…
Claire Harrison: MPN Does Not Define Your Dreams
Sep 6, 2026, 12:13 | Science
Claire Harrison: MPN Does Not Define Your Dreams
Claire Harrison, Professor of Haematology and Director of Analytics, Data and Research at Guy's and…
Anticoagulation and Contemporary Secondary Prevention of Thrombosis in Polycythemia Vera
Sep 5, 2026, 07:35 | Blog
Anticoagulation and Contemporary Secondary Prevention of Thrombosis in Polycythemia Vera
Thrombosis remains the leading preventable cause of morbidity and mortality in polycythemia vera (PV). Once…
Ruben Mesa: FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia
Aug 31, 2026, 14:28 | Voices
Ruben Mesa: FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia
Ruben Mesa, President of Cancer National Service Line at Advocate Health, shared a post on LinkedIn:…
Christina Hart: New Review on Coagulation Disorders in Philadelphia Chromosome-Negative MPNs
Jul 25, 2026, 12:06 | Science
Christina Hart: New Review on Coagulation Disorders in Philadelphia Chromosome-Negative MPNs
Christina Hart, Senior Physician at Regensburg University Hospital, shared on LinkedIn about a recent article she…
Does MPN Change the Outlook After Splanchnic Vein Thrombosis? - JTH
Jul 8, 2026, 16:09 | Science
Does MPN Change the Outlook After Splanchnic Vein Thrombosis? - JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Amica…
Mandy Lauw: International Collaboration Provides New Evidence for Splanchnic Vein Thrombosis Care
Jul 7, 2026, 19:47 | Science
Mandy Lauw: International Collaboration Provides New Evidence for Splanchnic Vein Thrombosis Care
Mandy Lauw, Internist-Hematologist at Erasmus MC, reposted from JTH on LinkedIn, about a recent article…
Gabriela Hobbs: Outcomes of MPN Patients with Concurrent Driver Mutations
Jul 4, 2026, 12:24 | Science
Gabriela Hobbs: Outcomes of MPN Patients with Concurrent Driver Mutations
Gabriela Hobbs, Leukemia Clinical Director at Massachusetts General Hospital, Associate Professor at Harvard Medical School,…
Naveen Pemmaraju: Pacritinib Versus Momelotinib in Thrombocytopenic Myelofibrosis
Jun 27, 2026, 13:40 | Science
Naveen Pemmaraju: Pacritinib Versus Momelotinib in Thrombocytopenic Myelofibrosis
Naveen Pemmaraju, Executive Director-Cancer Medicine for MDACC Cancer Network, shared a post on LinkedIn about…
Jean-Jacques Kiladjian: Building the Next Generation of MPN Leaders
Jun 25, 2026, 14:30 | Voices
Jean-Jacques Kiladjian: Building the Next Generation of MPN Leaders
Jean-Jacques Kiladjian, Head of Clinical Research Department of Inserm, Professor of Medicine at the University…
Bruna Velosa Ferreira: PV and ET - Beyond Blood Count Control
Jun 17, 2026, 14:54 | Voices
Bruna Velosa Ferreira: PV and ET - Beyond Blood Count Control
Bruna Velosa Ferreira, Hematologist at the Champalimaud Clinical Center, shared a post on LinkedIn: "PV and…
Ruben Mesa: Honoring MPN Legend Prof. Claire Harrison
Jun 13, 2026, 02:23 | Voices
Ruben Mesa: Honoring MPN Legend Prof. Claire Harrison
Ruben Mesa, President, Cancer National Service Line at Advocate Health, shared a post on LinkedIn: "Incredibly…
Eugene Fan: FIBOM-AI - Predicting Marrow Fibrosis From Routine Blood Counts
Jun 6, 2026, 05:59 | Science
Eugene Fan: FIBOM-AI - Predicting Marrow Fibrosis From Routine Blood Counts
Eugene Fan, Senior Consultant at Tan Tock Seng Hospital, shared a post on LinkedIn about a recent…
Scientific Excellence and Clinical Innovationat the 2026 Hadassah Hematology Conference - RFHMO
May 16, 2026, 16:23 | Organizations
Scientific Excellence and Clinical Innovationat the 2026 Hadassah Hematology Conference - RFHMO
Research Fund of the Hadassah Medical Organization (RFHMO) shared a post on LinkedIn: "On February 12-13,…
Polycythemia Vera and Thrombosis: Pathogenesis and Prevention
May 11, 2026, 11:59 | Blog
Polycythemia Vera and Thrombosis: Pathogenesis and Prevention
Polycythemia vera (PV), a JAK2-mutated myeloproliferative neoplasm, drives multilineage proliferation through constitutive JAK–STAT activation, creating…
Matt Simmonds: Having a Really Fabulous Time at the BSH 2026 Conference
Apr 23, 2026, 22:56 | Voices
Matt Simmonds: Having a Really Fabulous Time at the BSH 2026 Conference
Matt Simmonds, Senior Lecturer and Programme Lead for Biomedical Science at University of Lincoln,  shared…
Hisam Siddiqi: Understanding Bone Marrow Trephine Morphology in MPNs
Apr 8, 2026, 17:56 | Voices
Hisam Siddiqi: Understanding Bone Marrow Trephine Morphology in MPNs
Hisam Siddiqi, Consultant Haematologist at LycaHealth, The Blackheath Hospital, Dartford and Gravesham NHS Trust, shared…
Seema Dawood: What is Polycythemia Vera?
Apr 7, 2026, 17:21 | Voices
Seema Dawood: What is Polycythemia Vera?
Seema Dawood, Medical Laboratory Technologist at The Aga Khan University Hospital, shared a post on Linkedin:…
Narendra Bhattarai: Never Label Thrombocytosis as ET Without Excluding CML
Mar 5, 2026, 14:42 | Voices
Narendra Bhattarai: Never Label Thrombocytosis as ET Without Excluding CML
Narendra Bhattarai, Attending Hematopathologist at Rochester Regional Health, shared a post on LinkedIn: "Marked thrombocytosis.…
Abdul Mannan: What’s Your Approach When JAK2 Shows Up in Unusual Thrombosis?
Jan 5, 2026, 09:23 | Insight
Abdul Mannan: What’s Your Approach When JAK2 Shows Up in Unusual Thrombosis?
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared on LinkedIn: ''You find…
Arterial or Atypical Clots? Think APLS, PNH, and MPN
Dec 19, 2025, 11:34 | Insight
Arterial or Atypical Clots? Think APLS, PNH, and MPN
Allison Fitzgerald, Heme/Onc Fellow at Dana-Farber, posted on X: ''Today I learned that while clots…
Normal Counts, High Risk: Abdul Mannan Breaks Down JAK2 + Splanchnic Vein Thrombosis
Dec 12, 2025, 22:27 | Science
Normal Counts, High Risk: Abdul Mannan Breaks Down JAK2 + Splanchnic Vein Thrombosis
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, posted on LinkedIn: ''You find…
Abdul Mannan: When Blood Clots Show Up in Unexpected Places
Dec 12, 2025, 05:27 | Voices
Abdul Mannan: When Blood Clots Show Up in Unexpected Places
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:…
Zehraan Ibni Akbar: Polycythemia - A Closer Look into Myeloproliferative Disorders
Nov 24, 2025, 12:04 | Insight
Zehraan Ibni Akbar: Polycythemia - A Closer Look into Myeloproliferative Disorders
Zehraan Ibni Akbar, Laboratory Technician at Biomedicare Clinical Laboratory, posted on LinkedIn: ''Polycythemia: A Closer…
New Proteomic Insights into MPN Thrombosis from Blanca De Moner and Team
Nov 22, 2025, 13:57 | Science
New Proteomic Insights into MPN Thrombosis from Blanca De Moner and Team
Blanca De Moner Rafel, Researcher, PHD Student at Josep Carreras Leukaemia Research Institute, posted on…
Shivani Modi Highlights SOHO 2025 Study Linking Elevated WBC Counts to Increased Thrombosis Risk
Sep 4, 2025, 22:00 | Insight
Shivani Modi Highlights SOHO 2025 Study Linking Elevated WBC Counts to Increased Thrombosis Risk
Shivani Modi, Hematology/Oncology fellow, aspirant at University of Nebraska Medical Center, shared on X: ''Insightful…
Managing Thrombosis in MPN: Emphasizing Early Intervention and Age-Based Care
Jun 13, 2025, 07:58 | Insight
Managing Thrombosis in MPN: Emphasizing Early Intervention and Age-Based Care
British Journal of Haematology has recently shared on X: “Thrombosis risk in MPN patients peaks within…
All: 33 Posts: 1 - 100
NewsFeed